| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |